UTMD logo

Utah Medical Products (UTMD)

Profile

Full Name

Utah Medical Products, Inc.

Ticker Symbol

UTMD

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

March 8, 1999

Indexes

Not included

Website

http://www.utahmed.com

Employees

155

Key Details

Price

$52.30(-0.19%)

Market cap

$171.64M(Small cap)

Last Dividend

$0.30

TTM Dividend yield

2.31%

Annual revenue

$40.90M(-18.56% YoY)

Annual EPS

$3.96(-13.35% YoY)

PE ratio

13.25

Next earnings date

Apr 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$52.30
UTMD price is $52.30

30-Day Relative Volume

0.59
UTMD 30-day relative volume is 0.59

Price Performance

Price Most recent change

-0.19%
UTMD price was down -0.19% on Apr 17, 2025

Price YTD change

-14.92%
UTMD price is down -14.92% since January 1st

Price 1-year change

-22.66%
UTMD price is down -22.66% year-on-year

Price 3-year change

-41.13%
UTMD price is down -41.13% over the past 3 years

Price Range

Price All-time high

$133.87
UTMD price is currently -60.93% below its historical high of $133.87

Price 3-year low

$52.27
UTMD price is currently +0.06% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$171.64M
UTMD market capitalization is $171.64 million

Market cap 3-year change

-47.14%
UTMD market capitalization is down -47.14% over the past 3 years

Market cap All-time high

$455.30M
UTMD market capitalization is currently -62.30% below its historical high of $455.30 million

Market cap sector rank

55.14%
UTMD market capitalization is higher than 55.14% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-8.54%
UTMD shares outstanding is down -8.54% year-on-year

Shares Outstanding 3-Year Change

-10.21%
UTMD shares outstanding is down -10.21% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.35
UTMD beta is 0.35

200-day SMA

$63.56
UTMD price is currently -17.71% below its 200-day simple moving average

50-day SMA

$57.57
UTMD price is currently -9.15% below its 50-day simple moving average

RSI

24.03
UTMD 14-day relative strength index is 24.03

Volume

0.59
UTMD 30-day relative volume is 0.59

ATR

$1.25
UTMD average true range is $1.25

10-day Historical Volatility

23.49%
UTMD 10-day historical volatility is 23.49%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.30
UTMD last dividend was $0.30 per share, with an ex-dividend date of March 14, 2025

Next Dividend

-
UTMD next dividend has not yet been announced

Dividend per share

Dividend per share

$1.20
UTMD annual dividend per share is $1.20

Dividend per share Sector Rank

50.57%
UTMD annual dividend per share is higher than 50.57% of companies in Healthcare sector

Dividend per share 1-Year Change

+1.27%
UTMD annual dividend per share is up +1.27% year-on-year

Dividend per share 3-Year Change

-57.97%
UTMD annual dividend per share is down -57.97% over the past 3 years

Dividend yield

Dividend yield

2.29%
UTMD annual dividend yield is 2.29%

Dividend yield Sector Rank

51.16%
UTMD annual dividend yield is higher than 51.16% of companies in Healthcare sector

Other

Payout ratio

30.70%
UTMD annual payout ratio is 30.70%

Dividends paid

$4.26M
UTMD annual dividends paid is $4.26 million

Free cash flow

$14.60M
UTMD annual free cash flow is $14.60 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$40.90M
UTMD annual revenue is $40.90 million

Revenue Analysts estimate

-
UTMD annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-18.56%
UTMD annual revenue is down -18.56% year-on-year

Revenue Sector rank

44.17%
UTMD annual revenue is higher than 44.17% of companies in Healthcare sector

EPS

EPS

$3.96
UTMD annual earnings per share is $3.96

EPS Analysts estimate

-
UTMD annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-13.35%
UTMD annual earnings per share is down -13.35% year-on-year

EPS Sector rank

94.78%
UTMD annual earnings per share is higher than 94.78% of companies in Healthcare sector

Profit

Gross profit

$24.14M
UTMD annual gross profit is $24.14 million

Gross margin

59.03%
UTMD annual gross profit margin is 59.03%

Operating profit

$13.59M
UTMD annual operating income is $13.59 million

Operating margin

33.23%
UTMD annual operating profit margin is 33.23%

Net income

$13.87M
UTMD annual net profit is $13.87 million

Net margin

33.92%
UTMD annual net profit margin is 33.92%

Expenses

Total expenses

$27.31M
UTMD annual total expenses is $27.31 million

Operating expenses

$10.55M
UTMD annual total operating expenses is $10.55 million

Cost of goods sold

$16.76M
UTMD annual cost of goods sold is $16.76 million

Selling, general & administrative expenses

$9.74M
UTMD annual SGA is $9.74 million

Depreciation and amortization

$2.85M
UTMD annual depreciation & amortization is $2.85 million

Interest expense

-
UTMD annual interest expense value is unknown

Income tax

$2.93M
UTMD annual income tax is $2.93 million

EBIT & EBITDA

EBIT

$13.59M
UTMD annual earnings before interest & taxes is $13.59 million

EBITDA

$13.59M
UTMD annual EBITDA is $13.59 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$122.54M
UTMD annual total assets is $122.54 million

Non current assets

$26.21M
UTMD annual long term assets is $26.21 million

Current assets

$96.33M
UTMD annual total current assets is $96.33 million

Cash and cash equivalents

$82.98M
UTMD annual cash & cash equivalents is $82.98 million

Accounts receivable

$4.24M
UTMD annual accounts receivable is $4.24 million

Inventory

$8.81M
UTMD annual inventory is $8.81 million

Liabilities

Total liabilities

$5.11M
UTMD annual total liabilities is $5.11 million

Long term liabilities

$1.35M
UTMD annual total long term liabilities is $1.35 million

Current liabilities

$3.76M
UTMD annual total current liabilities is $3.76 million

Accounts payable

$696.00K
UTMD annual accounts payable is $696.00 thousand

Debt

Total debt

$282.00K
UTMD annual total debt is $282.00 thousand

Total debt 1-year change

-4.41%
UTMD annual total debt is down -4.41% year-on-year

Long term debt

$282.00K
UTMD annual long term debt is $282.00 thousand

Short term debt

-
UTMD annual short term debt value is unknown

Equity & Capital

Shareholders equity

$117.43M
UTMD annual stockholders equity is $117.43 million

Book value

$117.43M
UTMD annual book value is $117.43 million

Retained earnings

$129.30M
UTMD annual retained earnings is $129.30 million

Working capital

$92.57M
UTMD annual working capital is $92.57 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$14.83M
UTMD annual cash flow from operations is $14.83 million

Cash from operations 1-year change

-33.44%
UTMD annual cash flow from operations is down -33.44% year-on-year

Cash from investing

-$208.00K
UTMD annual cash flow from investing activities is -$208.00 thousand

Cash from investing 1-year change

+67.45%
UTMD annual cash flow from investing activities is up +67.45% year-on-year

Cash from financing

-$23.84M
UTMD annual cash flow from financing activities is -$23.84 million

Cash from financing 1-year change

-472.34%
UTMD annual cash flow from financing activities is down -472.34% year-on-year

CAPEX

CAPEX

$235.00K
UTMD annual capital expenditures is $235.00 thousand

CAPEX 1-year change

-63.22%
UTMD annual capital expenditures is down -63.22% year-on-year

Free Cash Flow

Free cash flow

$14.60M
UTMD annual free cash flow is $14.60 million

Free cash flow 1-year change

-32.56%
UTMD annual free cash flow is down -32.56% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

59.03%
UTMD annual gross profit margin is 59.03%

Operating margin

33.23%
UTMD annual operating profit margin is 33.23%

Net margin

33.92%
UTMD annual net profit margin is 33.92%

ROA & ROE

ROA

10.76%
UTMD annual return on assets is 10.76%

ROE

11.29%
UTMD annual return on equity is 11.29%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

13.25
UTMD price to earnings ratio is 13.25

PE ratio Sector rank

23.53%
UTMD price to earnings ratio is higher than 23.53% of companies in Healthcare sector

PB Ratio

PB ratio

1.46
UTMD price to book ratio is 1.46

PB ratio Sector rank

55.07%
UTMD price to book ratio is higher than 55.07% of companies in Healthcare sector

PS Ratio

PS ratio

4.20
UTMD price to sales ratio is 4.20

PS ratio Sector rank

62.13%
UTMD price to sales ratio is higher than 62.13% of companies in Healthcare sector

Enterprise value

Enterprise value

$88.94M
UTMD enterprise value is $88.94 million

Enterprise value Sector rank

48.43%
UTMD enterprise value is higher than 48.43% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

5.41
UTMD EV/EBITDA is 5.41

EV/EBITDA Sector rank

78.59%
UTMD EV/EBITDA is higher than 78.59% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

25.64
UTMD annual current ratio is 25.64

Quick ratio

23.29
UTMD annual quick ratio is 23.29

Leverage

Debt to equity

0.00
UTMD annual debt to equity ratio is 0.00

Interest coverage ratio

-
UTMD annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

8
UTMD piotroski f-score is 8

Altman Z-Score

23.23
UTMD altman z-score is 23.23

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

NGNE logo
Neurogene (NGNE)
VYGR logo
Voyager Therapeutics (VYGR)
CDXS logo
Codexis (CDXS)
GNFT logo
Genfit SA (GNFT)
MASS logo
908 Devices (MASS)
INMB logo
INmune Bio (INMB)
American Oncology Network (AONC)
RZLT logo
Rezolute (RZLT)
INBX logo
Inhibrx Biosciences (INBX)
  • What is the ticker symbol for Utah Medical Products?
  • Does Utah Medical Products pay dividends?
  • What sector is Utah Medical Products in?
  • What industry is Utah Medical Products in?
  • What country is Utah Medical Products based in?
  • When did Utah Medical Products go public?
  • Is Utah Medical Products in the S&P 500?
  • Is Utah Medical Products in the NASDAQ 100?
  • Is Utah Medical Products in the Dow Jones?
  • When was Utah Medical Products's last earnings report?
  • When does Utah Medical Products report earnings?

What is the ticker symbol for Utah Medical Products?

The ticker symbol for Utah Medical Products is NASDAQ:UTMD

Does Utah Medical Products pay dividends?

Yes, Utah Medical Products pays dividends. The last payment was $0.30, with an ex-dividend date on March 14, 2025

What sector is Utah Medical Products in?

Utah Medical Products is in the Healthcare sector

What industry is Utah Medical Products in?

Utah Medical Products is in the Medical Instruments & Supplies industry

What country is Utah Medical Products based in?

Utah Medical Products is headquartered in United States

When did Utah Medical Products go public?

Utah Medical Products's initial public offering (IPO) was on March 8, 1999

Is Utah Medical Products in the S&P 500?

No, Utah Medical Products is not included in the S&P 500 index

Is Utah Medical Products in the NASDAQ 100?

No, Utah Medical Products is not included in the NASDAQ 100 index

Is Utah Medical Products in the Dow Jones?

No, Utah Medical Products is not included in the Dow Jones index

When was Utah Medical Products's last earnings report?

Utah Medical Products's most recent earnings report was on Jan 28, 2025

When does Utah Medical Products report earnings?

The next expected earnings date for Utah Medical Products is Apr 25, 2025
On this page